alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
| · | our Independent Auditors' Report dated February 23, 2011 on the consolidated balance sheets of North American Palladium Ltd. as at December 31, 2010 and December 31, 2009, and the consolidated statements of operations, comprehensive loss and deficit, cash flows and shareholders’ equity for each of the years in the three-year period ended December 31, 2010 |
|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| · | our Report of Independent Registered Public Accounting Firm dated March 31, 2011 on the consolidated balance sheets of North American Palladium Ltd. as at December 31, 2010 and December 31, 2009, and the consolidated statements of operations, comprehensive loss and deficit, cash flows and shareholders’ equity for each of the years in the three-year period ended December 31, 2010 |
|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| · | our Report of Independent Registered Public Accounting Firm dated March 31, 2011 on North American Palladium Ltd.’s internal control over financial reporting as of December 31, 2010 |
|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----
<PAGE>   1


                                                                EXHIBIT 10.56

                           ALLONGE TO PROMISSORY NOTE

Amount:  $100,000                                           Detroit, Michigan

Dated:  March 27, 1997

     UNDER date of November 15, 1996, the undersigned ("Borrower") made and
delivered to the Jay F. Joliat Qualified Terminable Interest Marital Trust,
u/a/d 4-8-82 ("Lender") a Secured Promissory Note in the principal amount of
$100,000 (the "Note").

     At this time, Borrower has requested that Lender adjust the rate at which
interest accrues on the unpaid principal balance under the Note.

     Accordingly, Lender and Borrower hereby agree to amend the Note in the
following particular:

     1. Rate at which interest accrues on the unpaid principal balance under
the Note is hereby modified from 14% to 10% per annum.

     2. The Lender is the Jay F. Joliat Qualified Terminable Interest Marital
Trust, u/a/d 4-8-82

     3. This Allonge is but an amendment to the Note by way of modification and
does not constitute payment, satisfaction or discharge of the Note or any
obligation thereunder.  The Note, the Loan Commitment Letter and the Security
Agreement and all documents delivered by Borrower to secure its obligations
under the Note and any and all other documents executed by Borrower in
connection with the delivery of the Note are hereby ratified and confirmed as
being in full force and effect, as modified hereby.  In addition, Borrower
represents and warrants that it has no defense to payment or claims of  offset
under the Note.

THIS ALLONGE HAS BEEN EXECUTED AND DELIVERED ON MARCH 27, 1997.

BORROWER:

Caraco Pharmaceutical Laboratories, Ltd.,
a Michigan corporation

By: /s/ William R. Hurd
   --------------------------------
William R. Hurd
Its:  President and Chief Operating Officer

ACCEPTANCE:

     THE UNDERSIGNED hereby accepts the foregoing Allonge Promissory Note in
accordance with its terms.




JAY F. JOLIAT QUALIFIED TERMINABLE
INTEREST MARITAL TRUST, U/A/D 4-8-82


/s/ Jay F. Joliat
--------------------------------------
Jay F. Joliat, Individually and as Trustee
EXHIBIT 32.1

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

      In connection with the Quarterly Report of Science Dynamics Corporation
(the "Company") on Form 10-QSB for the quarter ended September 30, 2005 as filed
with the Securities and Exchange Commission on the date hereof (the "Report"),
I, Paul Burgess, Chief Executive Officer of the Company, certify, pursuant to 18
U.S.C. section 906 of the Sarbanes-Oxley Act of 2002, that:

      (1) The Report fully complies with the requirements of section 13(a) or
15(d) of the Securities and Exchange Act of 1934; and

      (2) The information contained in the Report fairly presents, in all
material respects, the financial condition and result of operations of the
Company.

      A signed original of this written statement required by Section 906 has
been provided to the Company and will be retained by the Company and furnished
to the Securities and Exchange Commission or its staff upon request.


November 22, 2005                       /s/ Paul Burgess
                                        ------------------------------------
                                        Paul Burgess
                                        Chief Executive Officer
Exhibit 32.1



CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT
OF 2002



In connection with the Quarterly Report
of Lattice, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2014 as filed with the Securities and
Exchange Commission on the date hereof (the “Report”), I, Paul Burgess, Chief Executive Officer of the Company, certify,
pursuant to 18 U.S.C. section 1350 of the Sarbanes-Oxley Act of 2002, that:



| | (1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- | ---------------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------



|Date: May 15, 2014 | By: | /s/Paul
    Burgess                                         
|------------------ | --- | ------------------------------------------------------------
|                   |     | Paul Burgess
        President (principal executive officer)
USCIB: 5.3/96 H..vmY: I/IA SGHI~ SHMff&S ONfiY 

17 June 1955 

6!6RBf = l1. S. El:r:1!iS ONLY 

MEMORANDtM FOR THE MEMBERS OF USCIBEC: 

Subject: Approval of the Minutes of the Twenty-ninth (Special) 

Meeting of USCIBEC. 

USCIB 5.3/91 dated l June 1955. ' . Reference: 

1. Subject to the insertion of the attached corrected page in its 

appropriate place the minutes of the Twenty-ninth (Special) meeting of 

USCIB are approved. 

2. It is requested that the word TENTATIVE be deleted from the 

initial page of the minutes for each item considered and the word FINAL 

substituted therefor. 

/J.4---~£ 4. • ..,__, 

~ H. D. JONFS 

Acting Executive Secretary, USCm 

Enclosures () ~ . ~ _ ~ ~ . 

Corrected p~~t minutes. - Correction sheet. 

USCIB: 5.3/96 

Declassified and approved for release by NSA on 03-25-2014 pursuant to E. 0. 1352B 

SECRE'T 

24 
~r!R~lp:-: AS 7 so. 

sgom Y.s. E¥m QNIX 

Page, Para 

of Final Copy 

Page 4, 

Para 2 

TWENTY-NINTH (SPECIAL) MEETING 

OF THE 

USCIR EXECUTIVE CG1MITTEE 

CORRECTION SHEEr 

TENTATIVE: 

FINAL: 

TEXT (Tentative and Final) 

''MR. POLYZOIDF.s explained that he is 

interested in a method of procedure and 

in preparing State's paper had tried to 

avoid old methods which had been 

rejected by NSA. He felt the State 

list to be extremely flexible, adaptable 

to all and when combined with the 

requirements of the other members would 

not increase in bulk ••• 11 

''MR. POLYZOIDES explained that he is 

interested in a met~od of procedure 

which would avoid the insufficiencies of 

the previous MRL and would lead as 

directly as possible to allocation or 

production resources. In preparing 

State's paper, the effort had been made 

to avoid old methods which had been 

rejected by NSA. He felt the State list 

to be extremely flexible and adaptable 

to the needs of the other agencies. 

When combined with the requirements of 

the other members it would not increase und~ in bulk ••• n 

Enclosure with USCIB 5.3/96. 

SECRET
NRO APPROVED FOR 

RELEASE 1 JULY,2015 " rT 

EXECUTIVE OFFICE OF THE PRESIDENT 

OFFICE OF SCIENCE AND TECHNOLOGY 

WASHINGTON 

RT DATA EN ERREDATE 6,257 -

VJ MICROFICHE , ori 

DATE (.0 DI

?

S 1 

Dear Al: 

HANDLE VIA aYEMAN 

CONTROL SYSTEM ONLY 

DORIAN 

April 21, 1965 

4 

The purpose of this letter is to pass on to you a number of questions 

concerning several aspects of recent MOL studies which the Special 

Space Panel would like considered in preparations for its next briefing 

on the subject. Please understand that these questions are not meant 

to restrict your planning for the briefings in any way, but are simply 

suggestive of some aspects of the MOL program in which Panel members 

have indicated an interest. 

 In a few days I should be able to discuss with you a choice of time for 

 the briefing. In accord with our recent discussion, this will not be 

 planned earlier than May 24. Also, you should know that the total 

 time the Panel will have available to receive the briefings will probably 

,!em not exceed f ive hours. 

 The questions which have been suggested thus far are as follows: 

 (1) Using the current Titan LUX and/or the Titan LUC configurations 

cs, in a 1970 polar launch, what are the expected attainable values for 

 manned and unmanned versions of optical reconnaissance systems, 

!ne= of the following: 

(a) maximum nadir ground resolution 

(b) satellite life in orbit; crew rotation period 

(c) probability that a given number of targets (specified during 

satellite-mission life cycle) are usefully recorded with ground 

resolution of: 

■ 101111•111.11111111111 

(2) For the two classes of systems in (1) what are the estimated costs: 

(a) of system developments 

(b) per deployed operational system 

(c) per target with resolution of: 

BYE-52108/65 

' Cy. I of 2 copies 

DIAXX-3A CONTROLLED 
NRO APPROVED FOR 

RELEASE 1 JULY 2015 HANDLE VIA BYEMAiq 

CONTROL SYSTEM ONLY 

DORIAN - 2 - 

(3) What are the significant considerations in coming to conclusions 

concerning the following operational alternatives: 

(a) use of both manned and unmanned system 

(b) use of manned systems only 

(c) use of unmanned systems only 

(4) What are the relative operational advantages of manned and 

unmanned systems in terms of: launch flexibility; recovery of data; 

speed of reaction time to acquire data about specific target? 

(5) If the first flight version of the MOL is to be a purely experimental 

(rather than a quasi-operational) system, what are the considerations 

which tend to determine the total number of spacecraft to be ordered? 

(6) What are the main technical problems in optical reconnaissance, 

and in other areas of specifically military interest, not susceptible to 

definitive resolution by ground or aircraft supported studies, which it is 

intended to investigate with MOL? For which of such problems is the use 

of the Extended Apollo system impractical; and for what reasons? 

Sincerely Yours, 

CSC 

N. E. Golovin 

Dr. Albert C. Hall 

Deputy Director (Space) 

Department of Defense 

Washington, D. C. 

BYE-52108/65 

Cy. 1 of 2 copies
**Exhibit 21.1**

 

**LIST OF SUBSIDIARIES**

 

Bio-Detek, Incorporated, incorporated in Massachusetts. 

ZOLL Medical (U.K.) Ltd, incorporated in United Kingdom. 

ZOLL Medical Deutschland (GmbH), incorporated in Germany. 

ZOLL Medical Canada, Inc., incorporated in Canada. 

ZOLL Data Systems, Inc., incorporated in Delaware. 

ZOLL Medical France NRC, established in France. 

ZOLL Medical Australia, Pty. Limited, incorporated in Australia. 

ZOLL International Holding BV, incorporated in the Netherlands. 

ZOLL Medical New Zealand Pty. Limited, incorporated in New Zealand. 

ZOLL Circulation, Inc. (formerly Revivant Corporation), incorporated in Delaware. 

ZOLL Medical Österreich, GmbH, incorporated in Austria. 

ZOLL Securities Corporation, incorporated in Massachusetts. 

ZOLL Lifecor Corporation, incorporated in Delaware.
<TABLE> <S> <C>

<ARTICLE> 5

<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
REGISTRANT'S FORM 10-Q FOR THE QUARTER ENDED MARCH 31, 1996 AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS
INCLUDED IN SUCH REPORT.
</LEGEND>

<CIK>   0000350667
<NAME>  CARLYLE REAL ESTATE LIMITED PARTNERSHIP - XI

       
<S>                <C>
<PERIOD-TYPE>      3-MOS
<FISCAL-YEAR-END>  DEC-31-1996
<PERIOD-END>       MAR-31-1996

<CASH>                   2,390,411 
<SECURITIES>                  0    
<RECEIVABLES>            4,989,876 
<ALLOWANCES>                  0    
<INVENTORY>                   0    
<CURRENT-ASSETS>         7,380,287 
<PP&E>                 209,887,169 
<DEPRECIATION>          83,513,791 
<TOTAL-ASSETS>         143,541,530 
<CURRENT-LIABILITIES>   33,342,435 
<BONDS>                128,882,029 
<COMMON>                      0    
<PREFERRED-MANDATORY>         0    
<PREFERRED>                   0    
<OTHER-SE>             (24,733,711)
<TOTAL-LIABILITY-AND-EQUITY>143,541,530 
<SALES>                  8,252,436 
<TOTAL-REVENUES>         8,298,740 
<CGS>                         0    
<TOTAL-COSTS>            6,176,072 
<OTHER-EXPENSES>           180,295 
<LOSS-PROVISION>         8,500,000 
<INTEREST-EXPENSE>       3,856,670 
<INCOME-PRETAX>        (10,414,297)
<INCOME-TAX>                  0    
<INCOME-CONTINUING>    (10,071,811)
<DISCONTINUED>                0    
<EXTRAORDINARY>               0    
<CHANGES>                     0    
<NET-INCOME>           (10,071,811)
<EPS-PRIMARY>               (70.36)
<EPS-DILUTED>               (70.36)

        


</TABLE>
Exhibit 23.10

Consent of Wenchang Ni

I
consent to the inclusion in this annual report on Form 40-F of North American Palladium Ltd., which is being filed with the United States Securities and Exchange Commission, of references to my name and references to my involvement in the
preparation of Technical Report for Lac des Iles Mine, Ontario, Incorporating Prefeasibility Study for Life of Mine Plan (effective date of March 21, 2014) included in the 2013 Annual Information Form of North American
Palladium Ltd., dated March 31, 2014 (the AIF).

I also consent to the incorporation by reference in the
Registration Statement on Form S-8 (File No. 333-13766) and in the Registration Statement on Form F-10 (File No. 333-185656) of the references to my name and the above-mentioned information in the AIF.

Dated this 31st day of March, 2014.



|     |  |                        
|---- |  | -----------------------
|     | 
|Per: |  | /s/ Wenchang Ni, P.Eng.
|     |  | Wenchang Ni, P.Eng.    
|     |  | Senior Mining Engineer 
|     |  | Tetra Tech WEI Inc.
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM ALLAIRE
CORPORATION FINANCIAL STATEMENTS AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE
TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-END>                               JUN-30-1998
<CASH>                                           3,247
<SECURITIES>                                       496
<RECEIVABLES>                                    3,698
<ALLOWANCES>                                     (502)
<INVENTORY>                                        141
<CURRENT-ASSETS>                                 8,033
<PP&E>                                           6,497
<DEPRECIATION>                                 (2,197)
<TOTAL-ASSETS>                                  12,708
<CURRENT-LIABILITIES>                           17,724
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            97
<OTHER-SE>                                    (18,979)
<TOTAL-LIABILITY-AND-EQUITY>                    12,708
<SALES>                                          7,827
<TOTAL-REVENUES>                                 8,905
<CGS>                                              823
<TOTAL-COSTS>                                    2,425
<OTHER-EXPENSES>                                14,502
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                (7,886)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (7,886)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (7,886)
<EPS-BASIC>                                     (1.19)
<EPS-DILUTED>                                   (1.19)


</TABLE>
FOR PUBLICATION

UNITED STATES COURT OF APPEALS

FOR THE NINTH CIRCUIT

MICHAEL D. BRAMBLES,  No. 01-55716

Petitioner-Appellant, D.C. No.

v. CV-00-08180-

W. A. DUNCAN, Warden; C. A.  MMM

TERHUNE, Director, California ORDER

Department of Corrections, WITHDRAWING

Respondents-Appellees. OPINION 

Filed April 11, 2005

Before: David R. Thompson and Johnnie B. Rawlinson,

Circuit Judges, and William W Schwarzer,*

Senior District Judge.

ORDER

The previous opinion filed June 3, 2003, slip op. page

7173, amended September 2, 2003, slip op. page 12539, and

appearing at 330 F.3d 1197 (9th Cir. 2003), is withdrawn. It

may not be cited as precedent by or to this court or any district court of the Ninth Circuit. 

*The Honorable William W Schwarzer, Senior United States District

Judge for the Northern District of California, sitting by designation. 

4121
PRINTED FOR

ADMINISTRATIVE OFFICE—U.S. COURTS

BY THOMSON/WEST—SAN FRANCISCO

The summary, which does not constitute a part of the opinion of the court, is copyrighted

© 2005 Thomson/West.
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM
RETROSPETTIVA, INC. 10-KSB FOR YEAR ENDED DECEMBER 31, 1998 AND IS QUALIFIED IN
ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               DEC-31-1998
<CASH>                                         115,890
<SECURITIES>                                         0
<RECEIVABLES>                                1,902,751
<ALLOWANCES>                                 (186,054)
<INVENTORY>                                  8,470,702
<CURRENT-ASSETS>                            12,781,110
<PP&E>                                         163,951
<DEPRECIATION>                                  93,695
<TOTAL-ASSETS>                              12,911,476
<CURRENT-LIABILITIES>                        3,923,553
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                     6,258,190
<OTHER-SE>                                   2,729,733
<TOTAL-LIABILITY-AND-EQUITY>                12,911,476
<SALES>                                     27,534,536
<TOTAL-REVENUES>                            27,534,536
<CGS>                                       23,991,906
<TOTAL-COSTS>                               26,091,790
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             105,440
<INCOME-PRETAX>                              1,444,910
<INCOME-TAX>                                   629,363
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   815,547
<EPS-PRIMARY>                                     0.28
<EPS-DILUTED>                                     0.22
        

</TABLE>
[Federal Register Volume 80, Number 37 (Wednesday, February 25, 2015)]
[Notices]
[Pages 10200-10201]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-03871]


-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[File No. 500-1]


In the Matter of Calypte Biomedical Corporation, EC Development, 
Inc., and Information Architects Corporation (n/k/a Dakota Creative 
Group Corporation); Order of Suspension of Trading

February 20, 2015.
    It appears to the Securities and Exchange Commission that there is 
a lack of current and accurate information concerning the securities of 
Calypte

[[Page 10201]]

Biomedical Corporation because it has not filed any periodic reports 
since the period ended December 31, 2012.
    It appears to the Securities and Exchange Commission that there is 
a lack of current and accurate information concerning the securities of 
EC Development, Inc. because it has not filed any periodic reports 
since the period ended September 30, 2012.
    It appears to the Securities and Exchange Commission that there is 
a lack of current and accurate information concerning the securities of 
Information Architects Corporation (n/k/a Dakota Creative Group 
Corporation) because it has not filed any periodic reports since the 
period ended September 30, 2012.
    The Commission is of the opinion that the public interest and the 
protection of investors require a suspension of trading in the 
securities of the above-listed companies. Therefore, it is ordered, 
pursuant to Section 12(k) of the Securities Exchange Act of 1934, that 
trading in the securities of the above-listed companies is suspended 
for the period from 9:30 a.m. EST on February 20, 2015, through 11:59 
p.m. EST on March 5, 2015.

    By the Commission.
Jill M. Peterson,
Assistant Secretary.
[FR Doc. 2015-03871 Filed 2-24-15; 8:45 am]
BILLING CODE 8011-01-P